Exploiting endogenous anti-inflammatory pathways as a therapeutic approach to multiorgan inflammatory disease.
This Commentary highlights the article by Montero-Melendez et al, revealing novel protective properties of endogenous melanocortin receptor 3 on periodontal status in health and disease and suggesting a new genus of anti-arthritic bone-sparing therapeutics.